CNTX
Context Therapeutics Inc.
Set alert
0.19 USD -0.01 -6.25%
0.1888 Day range 0.203
0.1891 52-week range 3.36
- YTD
- -87.14%
- 1 year
- -83.27%
- Open
- 0.203
- Prev close
- 0.2017
- Mkt cap
- 17.37M
- Vol
- 1.01M
- Avg vol
- 1.53M
- EPS
- -0.48
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.1888
- High
- 0.203
- Forward P/E
- -3.38
- Beta
- 2.25
- Short ratio
- 2.79
- Inst. own
- 76.40%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 1.79
- 200-d avg
- 1.86
- 1y target
- 7.70
Financial health
Altman Z-Score
-5.58 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -3.9×
FY 2019 5y median -0.8× FY 2025
P/S 0.0×
FY 2019 5y median 0.0× FY 2025
P/B 2.3×
FY 2019 5y median 0.6× FY 2025
P/FCF -5.3×
FY 2019 5y median -0.9× FY 2025
EV/EBITDA -2.1×
FY 2019 5y median 1.2× FY 2025
EV/Sales 0.0×
FY 2019 5y median 0.0× FY 2025
FCF Yield -18.9%
FY 2019 5y median -116.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2019 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2019 5y median 0.0% FY 2025
ROE -59.7%
FY 2019 5y median -42.7% FY 2025
ROIC -65.5%
FY 2019 5y median -44.2% FY 2025
ROA -52.7%
FY 2019 5y median -39.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2019 FY 2025
Operating Income -32.7%
FY 2019 FY 2025
EPS (diluted) 17.4%
FY 2019 FY 2025
Free Cash Flow 9.9%
FY 2019 FY 2025
Financial Health
Current Ratio 8.5×
FY 2019 5y median 11.8× FY 2025
Quick Ratio 8.5×
FY 2019 5y median 11.8× FY 2025
Debt / Equity 0.0×
FY 2019 5y median 0.0× FY 2025
Net Debt / EBITDA 1.8×
FY 2019 5y median 2.4× FY 2025
Interest Coverage 0.0×
FY 2019 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2019 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2019 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31